Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
JACC: Heart Failure · 2024-06 · 12 (6) · 1044-1055
DOI: 10.1016/j.jchf.2023.08.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Heart Failure, 2024-06. Verfasst von Amgad Mentias und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Medicare, Heart Failure, Rural Population, Urban Population. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: NIMHD NIH HHS, NIMHD.
Abstract (Originalsprache)
BACKGROUND: Patterns and disparities in guideline-directed medical therapy (GDMT) uptake for heart failure with reduced ejection fraction (HFrEF) across rural vs urban regions are not well described. OBJECTIVES: This study aims to evaluate patterns, prognostic implications, and rural-urban differences in GDMT use among Medicare beneficiaries following new-onset HFrEF. METHODS: Patients with a diagnosis of new-onset HFrEF in a 5% Medicare sample with available data for Part D medication use were identified from January 2015 through December 2020. The primary exposure was residence in rural vs urban zip codes. Optimal triple GDMT was defined as ≥50% of the target daily dose of beta-blockers, ≥50% of the target daily dose of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker or any dose of sacubitril/valsartan, and any dose of mineralocorticoid receptor antagonist. The association between the achievement of optimal GDMT over time following new-onset HFrEF diagnosis and risk of all-cause mortality and subsequent HF hospitalization was also evaluated using adjusted Cox models. The association between living in rural vs urban location and time to optimal GDMT achievement over a 12-month follow-up was assessed using cumulative incidence curves and adjusted Fine-Gray subdistribution hazard models. RESULTS: A total of 41,296 patients (age: 76.7 years; 15.0% Black; 27.6% rural) were included. Optimal GDMT use over the 12-month follow-up was low, with 22.5% initiated on any dose of triple GDMT and 9.1% on optimal GDMT doses. Optimal GDMT on follow-up was significantly associated with a lower risk of death (HR: 0.89 [95% CI: 0.85-0.94]; P < 0.001) and subsequent HF hospitalization (HR: 0.93 [95% CI: 0.87-0.98]; P = 0.02). Optimal GDMT use at 12 months was significantly lower among patients living in rural (vs urban) areas (8.4% vs 9.3%; P = 0.02). In adjusted analysis, living in rural (vs urban) locations was associated with a significantly lower probability of achieving optimal GDMT (HR: 0.92 [95% CI: 0.86-0.98]; P = 0.01 Differences in optimal GDMT use following HFrEF diagnosis accounted for 16% of excess mortality risk among patients living in rural (vs urban) areas. CONCLUSIONS: Use of optimal GDMT following new-onset HFrEF diagnosis is low, with substantially lower use noted among patients living in rural vs urban locations. Suboptimal GDMT use following new-onset HFrEF was associated with an increased risk of mortality and subsequent HF hospitalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA.
- Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Hawken School, Gates Mills, Ohio, USA.
- Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
- School of Public Health, Department of Population Health, and Division of Cardiology, Long School of Medicine, University of Texas San Antonio, San Antonio, Texas, USA.
Förderung
- NIMHD NIH HHS
- NIMHD
Zitieren
APA
Mentias, A., Keshvani, N., Sumarsono, A., Desai, R., Khan, M. S., Menon, V., Hsich, E., Bress, A. P., Jacobs, J., Vasan, R. S., Fonarow, G. C., & Pandey, A. (2024). Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries. JACC: Heart Failure, 12(6), 1044-1055. https://doi.org/10.1016/j.jchf.2023.08.027
Vancouver
Mentias A, Keshvani N, Sumarsono A, Desai R, Khan MS, Menon V, et al. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries. JACC: Heart Failure. 2024;12(6):1044-1055. doi:10.1016/j.jchf.2023.08.027
BibTeX
@article{Mentias2024,
author = {Mentias, Amgad and Keshvani, Neil and Sumarsono, Andrew and Desai, Rohan and Khan, Muhammad Shahzeb and Menon, Venu and Hsich, Eileen and Bress, Adam P and Jacobs, Joshua and Vasan, Ramachandran S and Fonarow, Gregg C and Pandey, Ambarish},
title = {Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries},
journal = {JACC: Heart Failure},
year = {2024},
volume = {12},
number = {6},
pages = {1044--1055},
doi = {10.1016/j.jchf.2023.08.027}
}
EUVIMED